Stockreport

Opus Genetics to Participate in Upcoming Investment Conferences

Opus Genetics, Inc.  (IRD) 
PDF RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”), a clinical-stage biopharmaceutica [Read more]